Skip to main content
. 2018 Aug 23;13(8):e0202575. doi: 10.1371/journal.pone.0202575

Table 2. Incidence rates for hemorrhagic stroke, subdural hemorrhage, subarachnoid hemorrhage and traumatic intracranial hemorrhage by drug exposure group.

Antithrombotic treatment Hemorrhagic stroke Subdural hemorrhage Subarachnoid hemorrhage Traumatic intracranial hemorrhage
Events, No. Crude Rate, Events per 100 Person-Years (95% CI) Age and sex adjusted incidence rate, Events per 100 Person-Years (95% CI) Events, No. Crude Rate, Events per 100 Person-Years (95% CI) Age and sex adjusted incidence rate, Events per 100 Person-Years (95% CI) Events, No. Crude Rate, Events per 100 Person-Years (95% CI) Age and sex adjusted incidence rate, Events per 100 Person-Years (95% CI) Events, No. Crude Rate, Events per 100 Person-Years (95% CI Age and sex adjusted incidence rate, Events per 100 Person-Years (95% CI)
None 4967 0.027 (0.026–0.028) 0.034 (0.034–0.035) 2701 0.015 (0.014–0.015) 0.019 (0.019–0.020) 2076 0.011 (0.011–0.012) 0.012 (0.011–0.012) 4312 0.023 (0.023–0.024) 0.027 (0.026–0.028)
Aspirin 2103 0.11 (0.10–0.11) 0.053 (0.040–0.066) 967 0.048 (0.045–0.052) 0.021 (0.018–0.025) 399 0.020 (0.018–0.022) 0.015 (0.011–0.018) 1232 0.062 (0.058–0.065) 0.033 (0.027–0.040)
Warfarin 813 0.27 (0.25–0.28) 0.12 (0.099–0.15) 454 0.15 (0.13–0.16) 0.076 (0.058–0.093) 77 0.025 (0.020–0.031) 0.024 (0.013–0.034) 334 0.11 (0.098–0.12) 0.051 (0.041–0.061)
Aspirin plus Clopidogrel 83 0.11 (0.09–0.14) 0.049 (0.036–0.062) 77 0.11 (0.084–0.13) 0.069 (0.034–0.10) 24 0.033 (0.021–0.049) 0.019 (0.0096–0.028) 80 0.11 (0.087–0.14) 0.060 (0.043–0.076)
Aspirin-Dipyridamole 317 0.24 (0.21–0.27) 0.13 (0.088–0.18) 112 0.085 (0.070–0.10) 0.029 (0.023–0.036) 68 0.052 (0.040–0.065) 0.033 (0.019–0.047) 153 0.12 (0.098–0.14) 0.099 (0.0050–0.19)
Warfarin plus Aspirin 132 0.38 (0.32–0.45) 0.19 (0.12–0.25) 69 0.20 (0.15–0.25) 0.096 (0.051–0.14) 10 0.029 (0.014–0.052) 0.011 (0.0030–0.020) 52 0.15 (0.11–0.19) 0.049 (0.032–0.067)
Clopidogrel 57 0.13 (0.10–0.17) 0.085 (0.052–0.12) 49 0.11 (0.084–0.15) 0.083 (0.0050–0.16) 10 0.023 (0.011–0.043) 0.011 (0.0035–0.018) 46 0.11 (0.078–0.14) 0.069 (0.038–0.10)
Rivaroxaban 60 0.34 (0.26–0.43) 0.16 (0.11–0.21) 8 0.045 (0.019–0.088) 0.024 (0.0021–0.045) 5 0.028 (0.009–0.065) 0.012 (0.00038–0.023) 18 0.10 (0.060–0.16) 0.065 (0.015–0.12)
Dipyridamole 28 0.26 (0.17–0.37) 0.083 (0.046–0.12) 10 0.092 (0.044–0.17) 0.028 (0.0099–0.046) 1 0.0092 (0.00023–0.051) 0.0024 (-0.0023–0.0070) 10 0.092 (0.044–0.17) 0.040 (0.0033–0.077)
Dabigatran 21 0.13 (0.08–0.20) 0.044 (0.024–0.063) 9 0.056 (0.025–0.11) 0.022 (0.0062–0.039) 1 0.0062 (0.00016–0.034) 0.0017 (-0.0016–0.0050) 9 0.056 (0.025–0.11) 0.027 (-0.0013–0.056)
Ticagrelor plus Aspirin 7 0.079 (0.03–0.16) 0.062 (-0.000094–0.12) 6 0.068 (0.025–0.15) 0.059 (-0.0012–0.12) 3 0.034 (0.0070–0.099) 0.016 (-0.0036–0.034) 9 0.10 (0.047–0.19) 0.066 (0.010–0.12)
Apixaban 7 0.26 (0.10–0.54) 0.10 (0.022–0.18) 4 0.15 (0.041–0.38) 0.051 (-0.0038–0.11) 0 0.00 (0.00–0.14) 0.00 (0.00–0.00) 1 0.037 (0.00094–0.21) 0.012 (-0.011–0.035)
Warfarin plus Aspirin and Clopidogrel 9 0.45 (0.20–0.85) 0.26 (0.00077–0.51) 5 0.25 (0.081–0.58) 0.044 (0.0039–0.085) 1 0.050 (0.0013–0.28) 0.012 (-0.012–0.036) 2 0.10 (0.012–0.36) 0.022 (-0.0086–0.052)
Dabigatran plus Aspirin 6 0.24 (0.09–0.53) 0.13 (-0.034–0.29) 2 0.08 (0.0097–0.29) 0.054 (-0.040 to 0.15) 0 0.00 (0.00–0.15) 0.00 (0.00–0.00) 2 0.080 (0.0097–0.29) 0.055 (-0.039–0.15)
Rivaroxaban plus Aspirin 12 0.54 (0.28–0.95) 0.25 (0.069–0.43) 3 0.14 (0.028–0.40) 0.030 (-0.0051–0.065) 1 0.045 (0.0011–0.25) 0.021 (-0020- 0.062) 4 0.18 (0.049–0.46) 0.056 (-0.0046–0.12)
Aspirin-Dipyridamole plus Clopidogrel 5 0.47 (0.15–1.09) 0.19 (0.0071–0.37) 3 0.28 (0.058–0.82) 0.064 (-0.0093–0.14) 0 0.00 (0.00–0.34) 0.00 (0.00–0.00) 6 0.56 (0.21–1.22) 0.19 (0.034–0.34)
Other antithrombotic medication 15 0.38 (0.27–0.52) 0.16 (0.10–0.21) 8 0.080 (0.035–0.16) 0.029 (0.0079–0.050) 4 0.040 (0.011–0.10) 0.024 (0.052–2.43) 9 0.090 (0.041–0.17) 0.040 (0.0084–0.072)

Patients could have multiple treatment courses with one drug or with different drugs.